Pelabresib,Ruxolitinib
morphosys
['$mor', 'morphosys']
$mor morphosys presents multiple analyses of the manifest phase 2 trial investigating the potential of pelabresib in the treatment of myelofibrosis at eha 2022 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft